It teased the positive results in July. Along with Beyfortus (nirsevimab), it is also a potential rival to Pfizer's RSV vaccine Abrysvo, which can be given to women during pregnancy to protect ...

Upcoming market catalysts for the second quarter of 2025 include the US approval decisions for clesrovimab (MK-1654) for respiratory syncytial virus (RSV) prophylaxis, sebetralstat for hereditary ...

Getting vaccinated during pregnancy protects your newborn from severe infection during the first critical months of life.

The final obstacle to the routine use of Sanofi and AstraZeneca's Beyfortus to prevent respiratory syncytial virus (RSV) in the US has fallen after it was backed by Centres for Disease Control and ...

A study from Yale University today in JAMA Network Open reveals substantial protection by the preventive drug nirsevimab ...

After hours: March 11 at 7:57:42 PM EDT Loading Chart for AZN ...

After hours: 7 March at 7:17:50 pm GMT-5 Loading Chart for AZN ...